Business description
Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, and rare diseases. With the right combination of size and agility, the company continue to push themselves as a business and as individuals to deliver positive change.
Management board & Supervisory board
| CEO |
| David Loew |
| Management board |
| Yan Moore M.D., Aymeric Le Chatelier, Aidan Murphy Ph.D., Craig Marks, Francois Garnier, Gwenan White, Regis Mulot, Dominique Bery, Alexander McEwan |
| Supervisory board |
| - |
Company data
| Name: |
Ipsen SA |
| Address: |
65, quai Georges Gorse,65, quai Georges Gorse Boulogne-Billancourt 92100 |
| Phone: |
+33 1 58 33 50 00 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
https://www.ipsen.com |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
12/31 |
| Free Float: |
41.52% |
| IPO date: |
12/1/2005 |
Investor relations
| Name: |
Craig Marks |
| IR phone: |
+44 7584 349 193 |
| IR Fax: |
- |
| IR e-mail: |
-
|
